Medical/Pharmaceuticals
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
SHANGHAI and OSLO, Norway, July 2, 2019 /PRNewswire/ -- Asieris MediTech Co, Ltd (Asieris), aChina-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, and Photocure ASA (Photocure, PHO: OSE), The ...
2019-07-02 21:40
3009
Dachser India receives IATA CEIV Pharma certification
MUMBAI, India, July 2, 2019 /PRNewswire/ -- The International Airport Transport Association (IATA) recently awarded theMumbai and Hyderabad branches of Dachser India with the prestigious CEIV Pharma certification, recognizing the company for its excellence in transporting Life Science and Healthc...
2019-07-02 17:12
2855
Nanologica Starts Business Within Preparative Chromatography With a Profitable Agreement
STOCKHOLM, July 2, 2019 /PRNewswire/ -- Nanologica enters into an agreement with Chinese Yunbo Technology (Beijing) Co. for the delivery of preparative chromatography media to a value of approximately MUSD 14. With the agreement as foundation, Nanologica starts large scale production of silica at...
2019-07-02 16:35
2041
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019
Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia, July 2, 2019 /PRNewswire/ -- Global biotherapeutics leaderCSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at this ...
2019-07-02 06:15
7974
Inaugural Winner of the Mundipharma Cancer Care Challenge Shines at Innovfest Unbound
SINGAPORE, June 28, 2019 /PRNewswire/ -- The five finalist teams of the inaugural 'Mundipharma Cancer Care Challenge' pitched their ideas on how to harness the power of technology to improve the lives of cancer patients to a panel of judges atSoutheast Asia's largest innovation festival, Innovfes...
2019-06-28 17:57
3570
Integrated Operating Rooms to Grow Exponentially with Virtual Reality and Artificial Intelligence
Data-driven protocols to find significant growth opportunities in modern ORs, finds Frost & Sullivan SANTA CLARA, California, June 27, 2019 /PRNewswire/ -- The operating room (OR ) is transforming from a seemingly simple box into atechnology-powered, infection-free, and sleek surgical environment...
2019-06-27 22:04
2296
Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.
SHANGHAI, June 27, 2019 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., today announced the opening of JLABS @Shanghai, the world's largest JLABS and the first in Asia Pacific. The 4,400-square-meter facility, located inShanghai's Zhangjiang...
2019-06-27 19:13
12107
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)
SUZHOU, China, June 27, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company ("Lilly") jointly announced today that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for IBI301, a co-developed biosimilar pro...
2019-06-27 12:21
11448
Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors
BEIJING, June 27, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has received Investigational New Drug (IND) cleara...
2019-06-27 09:00
2864
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
PLYMOUTH MEETING, Pennsylvania, June 26, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial ("REVEAL 1") of VGX-3100, a novel DNA-based immunotherapy being tested to tre...
2019-06-26 21:47
3488
Purecircle Holdings Announces Name Change to Pure CE
SINGAPORE, June 26, 2019 /PRNewswire/ -- Pure CE Pte Ltd, formerly Purecircle Holdings Pte Ltd today announced that it changed its corporate name from "Purecircle Holdings" to "Pure CE". Pure CE updated its corporate name and branding to better reflect its identity as a leading private equi...
2019-06-26 17:21
3090
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Tan Xuguang: Unveiling New Quality Productivity in Power Solutions for Asia-Pacific Data Centers!
[Picked up by 302 media titles]
2024-06-19 21:25
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15513
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
12948
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9409